ÂÜÀòÂÒÂ×

Alena Freudenmann began their work experience in 2015 with a research internship at the Max Planck Institute for lung and heart research. In 2017, they worked as a student assistant at the Max-Planck-Institute for Neurobiology. The following year, they completed an internship at Roche. In 2019, they joined Universitätsspital Basel (USB) as a graduate research associate and worked there until 2020. Currently, Alena is a graduate research associate at FoRx Therapeutics, starting in September 2020.

Alena Freudenmann began their education at the Technical University of Munich in 2012, where they pursued a Bachelor's degree in Molecular Biotechnology. Alena successfully completed their undergraduate studies in 2015. Alena furthered their education at the same institution and earned a Master of Science (MS) degree in Molecular Biotechnology from the Technical University of Munich between 2016 and 2018.